Diamyd Medical
Pharmaceuticals, 100 Technology Dr, Pittsburgh, Pennsylvania, 15219, United States, 11-50 Employees
Phone Number: 46 86******
Who is DIAMYD MEDICAL
Diamyd Medical is a Swedish diabetes company developing precision medicine therapies for Type 1 Diabetes. The therapeutic diabetes vaccine Diamyd , an antigen-specific immunotherapy for t...
Read More
-
Headquarters: 100 Technology Dr, Pittsburgh, Pennsylvania, 15219, United States
-
Employees: 11-50
-
Revenue: $5 Million to $10 Million
Industry: Pharmaceuticals
SIC Code: 2834
|
NAICS Code: 623110 |
Show More
Does something look wrong? Fix it. | View contact records from DIAMYD MEDICAL
Diamyd Medical Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Diamyd Medical
Answer: Diamyd Medical's headquarters are located at 100 Technology Dr, Pittsburgh, Pennsylvania, 15219, United States
Answer: Diamyd Medical's phone number is 46 86******
Answer: Diamyd Medical's official website is https://diamyd.com
Answer: Diamyd Medical's revenue is $5 Million to $10 Million
Answer: Diamyd Medical's SIC: 2834
Answer: Diamyd Medical's NAICS: 623110
Answer: Diamyd Medical has 11-50 employees
Answer: Diamyd Medical is in Pharmaceuticals
Answer: Diamyd Medical contact info: Phone number: 46 86****** Website: https://diamyd.com
Answer: Diamyd Medical is a Swedish diabetes company developing precision medicine therapies for Type 1 Diabetes. The therapeutic diabetes vaccine Diamyd , an antigen-specific immunotherapy for the preservation of endogenous insulin production, is being evaluated in the ongoing Phase III trial DIAGNODE-3. The company is establishing a vaccine manufacturing facility in Umea for the manufacture of recombinant GAD65, the active ingredient in the diabetes vaccine. Diamyd Medical also develops the GABA-based investigational drug Remygen as a therapy for regeneration of endogenous insulin production and to improve hormonal response to hypoglycaemia. Diamyd Medical is one of the major shareholders in the stem cell company NextCell Pharma AB as well as in the artificial intelligence company MainlyAI AB. The Diamyd Medical share is traded on Nasdaq First North Growth Market, ticker DMYD B.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month